Bikramjit Singh Lairikyengbam

Title: Innovator Spotlight: Bikramjit Singh Lairikyengbam

Introduction:

Bikramjit Singh Lairikyengbam is a notable inventor based in Pune, India, recognized for his contributions in the field of medicinal chemistry. His work primarily focuses on the modulation of nicotinic acetylcholine receptors, which has significant implications for therapeutic applications in neurological disorders.

Latest Patents:

Lairikyengbam holds a patent for "Thiazole derivatives as alpha 7 nAChR modulators". This innovation discloses a compound formula where specific parameters are defined, providing a modulator for nicotinic acetylcholine receptors, particularly the alpha 7 subtype. The patent includes various forms such as pharmaceutically acceptable salts, polymorphs, solvates, and isomers, for use in treating conditions like Alzheimer's disease, mild cognitive impairment, and senile dementia. The patent also encompasses methods of preparation for these compounds and their intended therapeutic uses.

Career Highlights:

Bikramjit currently works with Lupin, Inc., an established player in the pharmaceutical industry, where he continues to refine his research and innovation in drug development. His patent highlights his commitment to addressing significant health challenges through science and technology.

Collaborations:

During his professional journey, Bikramjit has collaborated with talented colleagues such as Neelima Sinha and Navnath Popat Karche. Together, they contribute to advancing research that has the potential to enhance therapeutic options for patients in need.

Conclusion:

Bikramjit Singh Lairikyengbam exemplifies the spirit of innovation in the pharmaceutical field. His patented work on thiazole derivatives showcases his dedication to improving the quality of life for individuals suffering from cognitive disorders. Through his contributions, he is making a lasting impact in the realm of medicinal research.